Doctor-led chat may curb teen smartphone overuse

NCT ID NCT07685951

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests whether a dedicated medical consultation using a structured interview guide can help adolescents aged 12 to 17 reduce their smartphone screen time. Teens who spend more than 14 hours per week on their phones and score high on a screening questionnaire are randomly assigned to either the structured consultation or standard care. The goal is to see if this brief, focused conversation leads to healthier screen habits and less time on devices.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Structured interview guide
What this could lead to
If effective, this approach could give primary care doctors a practical tool to help teens reduce excessive screen time and its related health risks.
What could go wrong
This is a relatively small, early-stage behavioral study. Results may not apply broadly, and teens may not follow through on screen-time goals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adolescent aged 12 to 17 years at the time of enrolment (participants aged 17 must not have turned 18 on the day of inclusion). * Adolescent owning a smartphone, with usage \>14 hours/week and a score \>10/21 on the early overexposure screening questionnaire (e-KID). * Adolescent and parent(s) or legal guardian(s) able to understand the objectives of the research. * Adolescent whose parent(s) or legal guardian(s) have signed an electronic informed consent (e-Consent) prior to any study-related procedures. (The minor's signature will be sought but is not mandatory. In accordance with Article L1122-2, consent from one parent/legal guardian is sufficient for inclusion and data analysis; however, consent from both parents will be systematically sought.) \- Adolescent affiliated with a health insurance plan (either as the beneficiary or dependent). Exclusion Criteria: * Adolescent with severe psychiatric disorders (DSM-V diagnosis and/or treatment with amphetamines, neuroleptics, or psychotropic drugs). * Adolescent currently excluded from participation due to a previous or ongoing study. * Adolescent under legal guardianship or conservatorship (tutelle or curatelle). * Adolescent female who is pregnant or breastfeeding (self-reported). * Adolescent under judicial protection (sauvegarde de justice). * Adolescent in an emergency situation, with comprehension difficulties, or cognitive impairment. * Adolescent who does not speak or understand French. * Adolescent who opposes participation in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Screen time exposure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.